Biotechnology and nanotechnology

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

2 facets displayed. 0 facets selected.

Geography

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (6)

All (6) ((6 results))

  • Stats in brief: 88-001-X200900110802
    Geography: Canada
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2007/2008 were collected from selected federal government departments and agencies. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2009-03-04

  • Stats in brief: 88-001-X200800210604
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2006/2007 were collected from selected federal government departments and agencies.The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2008-06-02

  • Articles and reports: 88-003-X20060039534
    Geography: Canada
    Description:

    Bioproducts play an important role in the search for solutions to declining reserves of oil, increasing costs of oil extraction, increasing oil prices and increasing greenhouse gas (GHG) concentration. They also offer opportunities for rural economic development and diversification for farmers. This article summarizes ongoing work towards improving our understanding of the bioproduct concepts and their definitions.

    Release date: 2006-12-06

  • Articles and reports: 88-003-X20060019103
    Geography: Canada
    Description:

    This article summarizes the key results from the first national survey on bioproducts development. Bioproducts are an emerging component of the Canadian economy and their global development offers many economic, environmental and social opportunities and benefits for Canada.

    Release date: 2006-02-27

  • Articles and reports: 88F0006X2002004
    Description:

    Spin-off firms made up over 34% of the core group of firms from the 1999 biotechnology survey. They also made up over 112 of the 270 small (under 50 employees) size firms, by far the largest group of core biotechnology, and half of the human health related firms, the largest sector of biotechnology firms. Central to this paper is the question: What are the general characteristics of this sub-group of core biotechnology firms?

    Release date: 2002-03-28

  • Articles and reports: 88-003-X20020016149
    Geography: Canada
    Description:

    According to the report Profile of Spin-off Firms in the Biotechnology Sector, three out of every 10 companies in Canada's rapidly expanding biotechnology sector in 1999 were spin-offs. These firms, which range from corporate spin-offs to biotechnology companies created by universities and research hospitals, accounted for more than one-quarter of total revenues in 1999.

    Release date: 2002-02-15
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (6)

Analysis (6) ((6 results))

  • Stats in brief: 88-001-X200900110802
    Geography: Canada
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2007/2008 were collected from selected federal government departments and agencies. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2009-03-04

  • Stats in brief: 88-001-X200800210604
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2006/2007 were collected from selected federal government departments and agencies.The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2008-06-02

  • Articles and reports: 88-003-X20060039534
    Geography: Canada
    Description:

    Bioproducts play an important role in the search for solutions to declining reserves of oil, increasing costs of oil extraction, increasing oil prices and increasing greenhouse gas (GHG) concentration. They also offer opportunities for rural economic development and diversification for farmers. This article summarizes ongoing work towards improving our understanding of the bioproduct concepts and their definitions.

    Release date: 2006-12-06

  • Articles and reports: 88-003-X20060019103
    Geography: Canada
    Description:

    This article summarizes the key results from the first national survey on bioproducts development. Bioproducts are an emerging component of the Canadian economy and their global development offers many economic, environmental and social opportunities and benefits for Canada.

    Release date: 2006-02-27

  • Articles and reports: 88F0006X2002004
    Description:

    Spin-off firms made up over 34% of the core group of firms from the 1999 biotechnology survey. They also made up over 112 of the 270 small (under 50 employees) size firms, by far the largest group of core biotechnology, and half of the human health related firms, the largest sector of biotechnology firms. Central to this paper is the question: What are the general characteristics of this sub-group of core biotechnology firms?

    Release date: 2002-03-28

  • Articles and reports: 88-003-X20020016149
    Geography: Canada
    Description:

    According to the report Profile of Spin-off Firms in the Biotechnology Sector, three out of every 10 companies in Canada's rapidly expanding biotechnology sector in 1999 were spin-offs. These firms, which range from corporate spin-offs to biotechnology companies created by universities and research hospitals, accounted for more than one-quarter of total revenues in 1999.

    Release date: 2002-02-15
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: